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Acute Respiratory Distress Syndrome
Jessica Kaufman, RN, BSN
Introduction
Acute respiratory distress syndrome (ARDS) is defined as lung failure with a ratio of partial pressure 
oxygen (PaO2) to fraction of inspired oxygen (FiO2) <100 (Michaels, Hill, Long, Young, Sperley, Shanks, & 
Morgan, 2013).  ARDS is characterized by acute, widespread pulmonary inflammation due to infection 
(viral or bacterial), trauma, and/or inhaled toxins (Aokage, Palmer, Ichiba, & Takeda, 2015). 
Approximately 150,000 patients are diagnosed with ARDS each year in the U.S. with reported mortality 
rates varying from 20%-40% (Butt, Kurdowska, & Allen, 2016; Drahnak & Custer, 2015). Risk factors for 
developing ARDS following an acute lung injury include age, males, African American, history of 
alcoholism, smoking, obesity, and diabetes (Modrykamien & Gupta, 2015).  
Diagnosis of ARDS is based on acute respiratory failure associated with extensive pulmonary infiltrates 
not caused by fluid overload or cardiac failure (Butt, et al, 2016).  Most patients who develop ARDS 
require mechanical ventilation, and the actual acute respiratory distress syndrome typically develops 
within 2-5 days of hospitalization for an acute lung injury (Butt, et, al, 2016).  The radiographic chest image 
of a patient with ARDS is characterized by a “whiteout” of the lungs, or patchy alveolar opacities, 
suggesting alveolar edema (Hammer & McPhee, 2014, pp243).  The image on the left below compares a 
normal chest x-ray to that of a patient with acute respiratory distress syndrome. Notice in the image the 
“whiteout” appearance of  right lung in the ARDS patient.  The image on the right provides a “close-up” 
look at the alveolar edema. 
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Pathophysiology
After the initial injury or insult to the lung, the body’s innate immune response is activated.  An emerging theory in ARDS
development is pattern recognition receptors (PRRs), which are essential components of the body’s innate immune system, and 
can be described as part of the “first line of defense” (Butt, et al, 2016).  Pattern recognition receptors identify endogenous 
pathogen-associated molecular patterns (PAMPs) and non-endogenous damage-associated molecular patterns (DAMPs), then 
initiate the inflammatory signaling cascade of pro-inflammatory cytokines (Butt, et al, 2016).   Pro-inflammatory cytokines, 
including tumor necrosis factor, and interleukin -1, interleukin -6, and interleukin -8, are released, which recruit neutrophils to the 
lungs (Siegel, 2016).  Neutrophils invade the pulmonary tissue and release cytotoxic mediators, which include granular enzymes, 
bioactive lipids, complement and reactive oxygen metabolites.  The cytotoxic mediators release platelet activation factor, and 
lead to formation of microthrombi in pulmonary vasculature.  All of these cytotoxins can also lead to tissue necrosis, apoptosis, 
and autophagy and essentially, damage to the alveolar epithelium and the pulmonary capillary endothelium (Fujishima, 2014; 
Siegel, 2016).   The image below illustrates the process of ARDS pathology on the alveolus. 
Injury to the alveolar epithelium and pulmonary capillary endothelium causes increased alveolar permeability, leading to 
alveolar and interstitial edema (Drahnak & Custer, 2015).  The damaged capillary endothelium allows larger molecules and 
proteins to permeate out of the vasculature, and when the oncotic pressure favoring fluid resorption is lost, the protein dense 
fluid can flood the interstitial space (Siegel, 2016).   This increase in interstitial fluid, combined with damage to the alveolar 
epithelium causes the air spaces to be filled with the protein-dense fluid and debris from autophagic cells (Siegel, 2016).   The 
influx of fluid into the interstitium leads to a decrease in surfactant production, causing an increase in atelectasis and a decrease 
in lung compliance (Choi, 2009).  
Patients who develop acute respiratory distress syndrome can be expected to move through a continuum of three phases.  The 
first phase, often referred to as exudative, early, or acute phase, develops 1-7 days after the initial injury/insult to the lungs (Choi, 
2009).  This early phase is characterized by uncontrolled inflammatory changes to the alveolocapillary membrane, and an influx of 
protein dense fluid and blood, sometimes referred to as hemorrhagic exudate, into the alveoli.  Fibrin and plasma proteins 
develop a hyaline membrane on the alveolar walls that can impede gas exchange and decrease lung compliance (Aokage, Palmer, 
Ichiba, & Takeda, 2015).  
The second phase of ARDS is the proliferative (or organizing) phase, which develops 5-7 days after its onset, and can be 
characterized by the continued inflammation of the interstitium and proliferation of type II alveolar cells (Aokage, et al, 2015).  
Damage to type II alveolar cells also makes surfactant inactive, contributing even more to atelectasis and decreased lung 
compliance (Drahnak & Custer, 2015).  As the proliferative phase continues, granulation tissue becomes part of the alveolar 
septum and leads to organized fibrosis (Butt, et al, 2016).  
The fibrosis (late) stage is the third phase of the ARDS process, and is characterized by interstitial fibrosis, continued 
proliferation of type II cells, and chronic inflammation (Choi, 2009).  
Treatment for acute respiratory distress syndrome can be as complex as the disease itself.  Mechanical ventilation using low 
tidal volumes, lung protective and recruitment maneuvers, inhaled nitric oxide, prone positioning, and the use of corticosteroids 
are the most utilized treatments (Michaels, et al, 2013; Zampieri, Mendes, Ranzani, Taniguchi, Azevedo, Costa, & Park, 2013).  In 
the event of refractory hypoxemia and respiratory failure despite the therapies mentioned above, extracorporeal membrane 
oxygenation (ECMO) may be utilized (Turner, Rehder, Carmichael, Ozment, Al-Hegelan, Willifort, Peters, Noble, & Cheifetz, 2011).  
Conclusion
Acute respiratory distress syndrome is a life 
threatening condition that requires aggressive 
treatment with close monitoring.  Successful 
treatment of ARDS requires expert knowledge 
from physicians, advanced practice nurses, bedside 
nurses, and respiratory therapists; all of whom 
must understand the complex underlying 
pathophysiology and critical nature of this 
condition. 
Significance of 
pathophysiology and 
implications for nursing 
practice
Acute respiratory distress syndrome is a complex 
and often fatal complication of acute lung injury.  
The predisposing factors to the development of 
ARDS vary, and include direct injury such as 
pneumonia, aspiration of gastric contents, 
pulmonary contusion or vasculitis, and inhalation 
injury; or indirect methods of lung injury such as 
pancreatitis, drug overdose, and nonpulmonary
sepsis (Modrykamien & Gupta, 2015).  
Understanding the underlying pathophysiology of 
why a patient has developed pulmonary edema 
because of pancreatitis and sepsis may be difficult 
to “wrap your head around”.  That is why it is so 
important for medical and nursing staff to 
understand what is happening at the cellular 
level, so as to understand why the body is 
reacting in such a way, and why certain therapies, 
medications, and interventions are chosen to 
treat ARDS.  Health care providers must be 
vigilant in their critical thinking to properly care of 
an ARDS patient.  Physicians, mid-level providers, 
bedside nurses, and respiratory therapists must 
understand the signs and symptoms of ARDS, as 
well as the progression of disease, and be able to 
anticipate what a patient’s needs may become.  
Thorough monitoring of vital signs, ventilator 
requirements, lab values, and radiographical
imaging is crucial.  Potential complications must 
be anticipated, such as pressure ulcers, poor 
nutrition and wound healing, muscle wasting 
from prolonged bedrest and possible use of 
neuromuscular blockades, and altered mental 
status from sedation medications and/or 
hypoxemia.  If prone therapy is used, staff must 
ensure patient safety, and making sure all the 
invasive tubes, lines, etc. stay in place when 
repositioning. 
There are not currently any biomarker molecules that are useful in the predicted severity of ARDS, and the 
PaO2/FiO2 ratio is used as a clinical indicator of severity (Butt, et al, 2016).   Fuller, Granton, & McConachie 
(2015, pp363) describe the levels of severity of acute respiratory distress syndrome in three categories, based 
on the level of hypoxemia. 
• Mild- PaO2/FiO2 >200 or <300mmHg with positive end expiratory pressure (PEEP) >5cm H2O
• Moderate- PaO2/FiO2 >100 or <200mmHg with PEEP >5cm H2O
• Severe- PaO2/FiO2 <100mmHg with PEEP >5cm H2O
The pathophysiology of acute respiratory  syndrome is complex, and can result from a number of different 
insults.  No matter the mechanism of injury, the common consequence is increased permeability pulmonary 
edema (Hammer & McPhee, 2014, p 243).  A healthy, functioning lung is able to regulate a delicate balance 
between dry, patent alveoli and a very small amount of interstitial fluid.  Any injury to the lung can upset this 
balance, resulting in impaired gas exchange, decreased lung compliance, and an increase in pulmonary arterial 
pressures, all which can lead acute respiratory failure (Siegel, 2016).
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